IN VIVO, H 2 O 2 HAS BEEN SHOWN to mediate significant increases in endothelial solute permeability during pathological events such as inflammation and ischemia-reperfusion injury (14, 15, 20, 33) . Unfortunately, the mechanisms responsible for increased endothelial permeability are poorly understood. Many investigators have begun to address these questions using in vitro endothelial cell models (4, 35, 36, 37) . Human endothelial cell cultures have been used to study mechanisms of endothelial permeability in response to various agents, yet the precise mechanisms involved in H 2 O 2 -mediated permeability are still unknown (7, 24) .
The endothelial solute barrier is regulated and maintained by endothelial cell-cell junction proteins. Investigators have reported that endothelial solute barrier properties correlate with the amount and integrity of tight junctional complexes between endothelial cells (2, 3, 23, 24, 38, 39, 40, 44) . We have demonstrated that the endothelial tight junctional protein occludin is significantly involved in maintaining endothelial solute barrier properties (23, 24, 44) . With the use of antisense oligonucleotides directed at occludin mRNA, we have previously shown that a reduction in occludin expression in either human arterial or venous endothelial cells causes a loss of normal solute barrier, indicating that occludin is necessary for maintaining normal endothelial solute barrier. Hirase et al. (18) also has demonstrated that occludin is more abundant in vascular beds where the endothelial solute barrier is tight (e.g., blood-brain barrier). We have also shown that treatment of human umbilical vein endothelial cell (HUVEC) monolayers with vascular endothelial growth factor (VEGF) disorganized endothelial occludin junction organization, which involved the activation of extracellularly regulated kinase 1 and 2 (ERK1/ ERK2) (24) . The objective of this study was to determine the effects of H 2 O 2 exposure on occludin organization and endothelial tight junction function.
We report that H 2 O 2 administration caused an increase in HUVEC solute permeability that was accompanied by a loss of occludin localization from endothelial cell-cell junctions. Loss of occludin localization appeared to occur through increased occludin phosphorylation and decreased ZO-1 association. All of these events were blocked by inhibition of mitogenactivated protein (MAP) or ERK kinase 1 (MEK1), suggesting that ERK1/ERK2 signaling pathways are important for H 2 O 2 -mediated endothelial permeability. These data strongly suggest that H 2 O 2 -mediated increased endothelial permeability occurs through ERK1/ERK2-mediated loss of endothelial tight junction integrity.
MATERIALS AND METHODS
Tissue culture. HUVEC were cultured as previously reported (23, 24) . Cells were maintained in endothelial growth medium (EGM; Clonetics, San Diego, CA) and cultured on fibronectin-coated (Sigma, St. Louis, MO) tissue culture plates. Endothelial cells were used at passages 1 and 2 for all experiments reported.
Cell-column permeability assay. We used a previously reported bioassay for measurement of permeability across endothelial cell monolayers (22, 24) . Briefly, HUVEC were grown on fibronectin-coated cytodex-3 beads (Sigma). Cellcovered beads were poured into a water-jacketed glass column (maintained at 37°C) and perfused with a normal perfusate solution of Hanks' balanced salt solution containing 0.5% BSA (fraction V; Sigma) and 15 mM HEPES, pH 7.4 (Sigma). Permeability measurements were made by injecting 50 l of tracer dye (blue dextran mol mass 2,000 kDa, cyanocobalamin mol mass 1.355 kDa, and sodium fluorescein mol mass 0.376 kDa) onto the cell column and measuring the resultant elution profile. Data are expressed as percent permeability to sodium fluorescein. Permeability measurements were made under baseline, 1 mM H 2 O 2 , or 1 mM H 2 O 2 plus one of the following protein kinase inhibitors: tyrphostin 23 (50 M; Biomol, Plymouth, MA), chelerythrine chloride (750 nM; Biomol), or PD-98059 (20 M; Calbiochem, San Diego, CA). Cells were pretreated with inhibitor for 30 min and then exposed to the same inhibitor plus H 2 O 2 . Incubations were carried out for 90 min with measurements taken once after the addition of inhibitors and every 15 min thereafter. Four separate experiments were performed for each treatment group.
Immunofluorescent staining of occludin and ZO-1. HUVEC were cultured on fibronectin-coated glass coverslips. Upon confluency, coverslips were treated, fixed, and stained as previously reported (23, 24) . HUVEC coverslips were either pretreated with protein kinase inhibitors and then exposed to both the inhibitor plus H 2 O 2 , or exposed to H 2 O 2 alone. H 2 O 2 incubation periods, with or without inhibitors, were for 30 min. Treatments were removed, and coverslips were incubated with ice-cold 95% ethanol for 30 min at Ϫ20°C, then incubated with acetone for 1 min and left to air dry at room temperature. Primary antibodies of mouse anti-occludin (1: 250) and rabbit anti-ZO-1 (1:250; Zymed, San Francisco, CA) were added for 1 h at 37°C. Coverslips were then washed with 0.1% milk/PBS solution for 5 min three times each. Fluorescently labeled secondary antibodies (1:250) donkey anti-mouse FITC and donkey anti-rabbit Cy3 (Jackson Immunoresearch Laboratories, Westgrove, PA) were incubated at 37°C for 1 h. Coverslips were again washed with 0.1% milk/PBS solution for 5 min three times each. Coverslips were mounted with an antiquenching solution [1 mg/ml phenylenediamine (Sigma) in 50% glycerol, 50% PBS]. All photomicrographs were taken at ϫ100 with exposure times of 8 s. Three separate experiments were performed for all treatment groups.
Western blotting. Western blot analysis was performed as previously described (23, 44) . Cell lysates were prepared by adding 500 l of boiling sample buffer [125 mM Tris ⅐ HCl (pH 6.8), 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 25 g/ml aprotinin, 2 g/ml leupeptin, and 0.025% bromphenol blue] directly to a P60 culture dish. Ten percent SDS polyacrylamide gels were run with 120,000 cells of HUVEC per lane (50 g total protein). Gels were electrically transferred onto nitrocellulose membranes (Sigma) and blocked with blotto (5% milk powder in PBS) overnight. Membranes were cut in half and incubated in either mouse anti-occludin or rabbit anti-ZO-1 antibodies at a dilution of 1:2,000 for 2 h. Membranes were then washed in 0.1% milk/PBS three times for 5 min each wash. Secondary antibodies of goat anti-rabbit IgG-alkaline phosphatase and sheep anti-mouse IgG-alkaline phosphatase (Sigma) were incubated with the membranes for 2 h at a 1:2,000 dilution. Membranes were then washed three times with 0.1%/PBS for 5 min each and developed using nitro blue tetrazolium/bromochloroindolyl phosphate (NBT/BCIP; Sigma) colorimetric reagents. Three separate experiments were performed for each treatment group.
ERK1/ERK2 kinase phosphorylation. ERK1/ERK2 phosphorylation was determined by probing HUVEC cell lysates with an anti-active MAP kinase antibody (Promega, Madison, WI). Treatment protocols were as previously stated. Equal amounts of total protein (50 g) were electrophoresed on 12.5% SDS polyacrylamide gels. Gels were transferred and blotted using the anti-active MAP kinase antibody (1: 20,000) followed by goat anti-mouse horseradish peroxidase (1:5,000) secondary antibody (Sigma). Blots were developed using the enhanced chemiluminescence (ECL) detection system (Amersham, La Jolla, CA). Four separate experiments were performed for each treatment group.
Surface biotinylation of occludin. Endothelial monolayers were pretreated with PD-98059 (20 M) for 30 min. Cells were then incubated with H 2 O 2 ϩ PD-98059 (20 M), H 2 O 2 , or PD-98059 (20 M) alone for 30 min. After the 30-min treatment period, cells were placed on ice and washed twice with ice-cold PBS. Cell monolayers were then labeled with 200 g/ml biotin in PBS (Sigma) for 20 min on ice. The biotin solution was removed, and the reaction was quenched with serum-free DMEM. Cell monolayers were washed twice with ice-cold PBS and lysed in 1 ml of RIPA buffer [150 mM NaCl, 50 mM Tris (pH 8.0), 1% Triton X-100, 0.1% SDS, 1 g/ml leupeptin, 5 g/ml aprotinin, 1 mM PMSF, 500 M sodium metavanadate, and 100 M okadaic acid]. Immunoprecipitation of occludin was done as previously described (11, 21) . Occludin protein was immunoprecipitated by adding 4 g of rabbit anti-occludin polyclonal antibody (Zymed) and rotating at 4°C for 2 h. Thirty microliters of protein A-Sepharose beads (Sigma) were added and samples rotated at 4°C for 1 h. Protein A beads were pelleted by centrifugation, and the supernatant was removed. Pellets were washed four times with RIPA buffer. Sample buffer was added to each tube, boiled for 3 min, and loaded on 10% SDS polyacrylamide gels. Gels were electrophoresed and transferred to nitrocellulose. Blots were blocked with 5% milk/PBS solution overnight at 4°C. The blots were then cut in half, and the upper portion was reacted with rabbit anti ZO-1 antibody as previously described while the lower portion was reacted with avidin alkaline phosphatase (1:500) for 2 h at room temperature. The blots were developed using NBT/BCIP colorimetric reagents (Sigma). Normalization to immunoprecipitated occludin was performed using a monoclonal mouse anti-occludin antibody (1:1,000; Zymed) followed by incubation with goat anti-mouse horseradish peroxidase secondary antibody (1: 15,000; Bio-Rad, Hercules, CA) and developed using the ECL detection system (Amersham). Four separate experiments were performed for each treatment group.
Phosphoserine detection of occludin. HUVEC were exposed to H 2 O 2 , H 2 O 2 ϩ PD-98059, or PD-98059 treatment protocols. Four micrograms of rabbit anti-occludin was added to the cell lysates and immunoprecipitated as described. Pelleted samples were electrophoresed using SDS polyacrylamide gels. Gels were transferred to nitrocellulose and blocked with 1% BSA/PBS solution. Blots were incubated with mouse anti-phosphoserine monoclonal antibody (1:1,000; Sigma) for 2 h at room temperature. Blots were washed three times with 0.1% BSA/PBS solution and incubated with goat anti-mouse horseradish peroxidase conjugated secondary antibody (1:15,000; Bio-Rad) for 2 h at room temperature. Blots were washed again and developed using the ECL detection system (Amersham). Normalization of the blots was performed using mouse anti-occludin or rabbit anti-ZO-1 antibodies and developed using NBT/BCIP. Four separate experiments were performed for each treatment group.
Densitometric and statistical analysis. Densitometry was performed using a Hewlett-Packard Scanjet IIcx flatbed scanner and Image Pro Plus image analysis software (Media Cybernetics, Silver Spring, MD). Statistical analysis was performed using Instat statistical software (Graphpad Software, San Diego, CA). One-way ANOVA with Bonferroni posttesting was used to compare control vs. treatment groups for all experiments reported. Data are reported as mean Ϯ SD.
RESULTS
H 2 O 2 -mediated permeability occurs through MAP kinase pathways. HUVEC solute permeability was measured in response to 1 mM H 2 O 2 administration using the cell-column method of determining monolayer permeability. Figure 1 illustrates that H 2 O 2 initially caused significant increases in HUVEC solute permeability after 30 min and a maximal 2.5-fold increase in HUVEC solute permeability by 90 min. Importantly, we have previously shown that this increase in permeability is not due to loss of endothelial cells or cell death (22, 28) .
Based on the observation that H 2 O 2 can cause the activation of various signal transduction cascades in bovine pulmonary artery endothelial cells and other nonendothelial cell types, we sought to determine whether similar signal transduction pathways were involved in H 2 O 2 -mediated HUVEC permeability (4, 16, 22, 26, 27, 36, 45) . Figure 1 demonstrates that H 2 O 2 -mediated permeability was not prevented by the protein kinase C (PKC) inhibitor chelerythrine chloride (750 nM) or the tyrosine kinase inhibitor tyrphostin 23 (50 M). These observations are in contrast to reports using other nonhuman endothelial cell models (4, 22) . Several reports have shown that H 2 O 2 administration results in activation of ERK1/ERK2 (16, 19, 27) . We also have recently reported that HUVEC solute permeability due to VEGF administration involves ERK1/ERK2 activation (24) . Therefore, we examined the contribution of ERK1/ERK2 activity in H 2 O 2 -mediated permeability by inhibiting MEK1, the upstream activator of ERK1/ERK2. Administration of the MEK1 inhibitor PD-98059 (20 M) prevented H 2 O 2 -mediated increased permeability (Fig. 1) . Moreover, we have previously reported that PD-98059 itself does not alter solute permeability (24) . These data support our previous finding that MAP kinase activity is involved in solute barrier regulation of human endothelial cells and suggests that H 2 O 2 increases solute permeability through similar mechanisms.
H 2 O 2 -mediated phosphorylation of ERK1/ERK2. Previous studies have shown that exogenous H 2 O 2 administration can stimulate ERK1/ERK2 activity in endothelial and nonendothelial cell types (16, 19, 27) . We observed that a 30-min exposure to H 2 O 2 caused a significant increase in ERK1/ERK2 phosphorylation that was blocked by PD-98059 ( Fig. 2A) . Densitometric analysis of both ERK1 and ERK2 revealed that ERK1/ ERK2 phosphorylation was five times greater in H 2 O 2 -treated cells compared with control (Fig. 2B) . ERK1/ ERK2 activation by H 2 O 2 ϩ PD-98059 was not significantly different from control. These data suggest that H 2 O 2 administration results in increased HUVEC ERK1/ERK2 phosphorylation through MEK1-dependent mechanisms.
Immunofluorescent localization of the tight junctional proteins occludin and ZO-1. The normal basal solute permeability level of human venous and arterial endothelial cells are governed in part by the expression and localization of the tight junctional protein occludin (23, 24, 44) . These observations prompted us to examine the effects of H 2 O 2 administration on endothelial junctional localization of the tight junctional protein occludin and an associated linker protein ZO-1. Figure  3 , A and D shows control staining of HUVEC occludin and ZO-1, respectively. Control occludin staining (Fig.  3A) demonstrates that the protein is localized junctionally although more discontinuously compared with ZO-1 staining. Control ZO-1 is distributed continuously around the periphery of the endothelial cells (Fig.  3D) . After a 30-min exposure to H 2 O 2 , the endothelial cell junctions showed a loss of occludin junctional localization with subsequent punctate occludin staining (Fig. 3B) . However, H 2 O 2 treatment did not cause a dramatic loss of ZO-1 from the junction except for where gaps are observed (Fig. 3E, arrows) . This suggests that occludin and ZO-1 may functionally dissociate from one another during H 2 O 2 administration. H 2 O 2 ϩ PD-98059 treatment showed occludin and ZO-1 localization to be maintained and apparently enhanced at the endothelial cell-cell junction compared with control endothelial monolayers (Fig. 3, C and F) . 
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We have previously reported that PD-98059 itself does not alter endothelial junctional protein organization (24) . These data suggest that the MEK1/ERK1/ERK2 signal pathway is involved in H 2 O 2 -mediated loss of occludin junctional organization.
Levels of occludin and ZO-1 in H 2 O 2 -treated HUVEC monolayers. Levels of occludin protein expression can affect endothelial solute barrier properties. We have reported that a reduction of occludin protein levels through antisense oligonucleotide treatment decreases the level of barrier formation in arterial and venous endothelial monolayers (23) . Moreover, we have also shown that a model of transplantation injury using HUVEC monolayers resulted in a loss of occludin protein that was accompanied by an increase in solute permeability (44) . Figure 4 , A and B, illustrates the steady-state levels of ZO-1 and occludin after H 2 O 2 and H 2 O 2 ϩ PD-98059 exposures. Densitometric analysis of both the occludin (Fig. 4B ) and ZO-1 (Fig. 4A ) bands failed to show significant differences of these proteins Note that peroxide causes a loss of junctional occludin organization with the appearance of punctate occludin staining, whereas ZO-1 junctional localization was better maintained except for areas demonstrating gap formation (arrows). C and F illustrate the effects of combined administration of H 2 O 2 and PD-98059 (20 M) on occludin and ZO-1 dual junction localization, respectively. Note that junctional localization of both occludin and ZO-1 was maintained with an apparent enhancement of occludin organization. All fields were shot at ϫ100. Bar, 2.5 m.
between treatment groups. These data suggest that H 2 O 2 does not stimulate the loss or degradation of these proteins.
Surface organization of occludin and ZO-1 association. We have previously observed that endothelial adherens junctional proteins are endocytosed upon exposure to H 2 O 2 (22) . Therefore, we sought to determine whether occludin would also be endocytosed upon H 2 O 2 exposure. To determine the amount of occludin at the cell surface, cells were biotinylated after a 30-min incubation period with H 2 O 2 , H 2 O 2 ϩ PD-98059, or PD-98059 alone treatments. These cells were lysed, and a coimmunoprecipitation was performed for occludin and ZO-1 using a polyclonal occludin antibody. To determine the amount of biotinylated occludin, the immunoprecipitates were run on SDS polyacrylamide gels, and blots were probed with avidin alkaline phosphatase (Fig. 5A) . The upper portions of the blots were also probed for ZO-1 to determine the amount of occludin-ZO-1 interactions (Fig. 5B) . Densitometric analysis of the blots showed no significant difference in the amount of biotinylated occludin between control and H 2 O 2 -treated monolayers. This suggested that H 2 O 2 did not cause occludin endocytosis and that occludin was reorganized on the cell surface. Interestingly, the H 2 O 2 ϩ PD-98059 treatment revealed a threefold greater amount of biotinylated occludin, suggesting that this combination enhanced occludin surface localization. This observation supports our immunofluorescence data showing enhanced occludin junctional localization with H 2 O 2 ϩ PD-98059 (Fig. 3C) .
Densitometric analysis of coimmunoprecipitated ZO-1 revealed that H 2 O 2 exposure significantly decreased the occludin-ZO-1 associations by 60%. The combined treatment of H 2 O 2 ϩ PD-98059 showed that ZO-1 association with occludin increased similarly to the amount of occludin found at the cell surface (i.e., 3-fold greater than control). Control experiments with the PD-98059 compound alone did not demonstrate any significant difference in either occludin biotinylation or ZO-1 association compared with control. These data demonstrate that occludin-ZO-1 interactions are reduced in response to H 2 O 2 treatment and that occludin is redistributed across the endothelial cell surface. These data also further illustrate that the ERK1/ERK2 signal pathway is involved in maintaining occludin localization to the cell-cell junction and occludin-ZO-1 association.
Serine phosphorylation of occludin. Occludin has been reported to be phosphorylated on serine residues (34) . We sought to determine what effects H 2 O 2 had on serine phosphorylation of occludin. Treatment with H 2 O 2 resulted in a significant increase in occludin phosphoserine content (Fig. 6A) . Normalizing the phosphoserine signal to the amounts of immunoprecipitated occludin showed a significant threefold increase in serine phosphorylation, which was prevented by PD-98059 treatment (Fig. 6, A and B) . This is the first report directly demonstrating that occludin phosphorylation is associated with a loss of endothelial solute barrier properties. Moreover, our data suggest that occludin is not normally phosphorylated on serine residues under basal conditions.
DISCUSSION
Endothelial cell tight junctions have been shown to regulate and maintain endothelial solute barrier properties (3, 38, 39) . Recent reports have shown that the tight junctional protein occludin is intimately involved in maintaining endothelial solute barriers (23, 24, 44) . With the use of antisense oligonucleotides directed at occludin mRNA, we have shown that decreasing HUVEC occludin expression to less than one-half of control levels results in a significant increase in solute permeability (44) . We also have reported that substances such as VEGF and organ transplantation preservation solutions cause a loss of junctional occludin organization, decreased occludin expression, and increased endothelial solute permeability (24, 44) . These studies demonstrate that occludin is involved in the regulation and maintenance of endothelial solute barrier function. However, precise identification of the molecular mechanisms involved in the loss of endothelial solute barrier and occludin organization are lacking. This report correlates the molecular mechanisms and signal transduction pathways that may be involved in the loss of normal endothelial solute barrier.
Several studies have shown that pathological conditions such as ischemia-reperfusion and leukocyte-me- Fig. 6 . Effects of H 2 O 2 on occludin phosphoserine content. HUVEC monolayers were exposed to H 2 O 2 , H 2 O 2 ϩ PD-98059 (20 M), or PD-98059 alone. Occludin was immunoprecipitated and probed for phosphoserine content. A: occludin is phosphorylated on serine residues in response to H 2 O 2 administration. Combined treatment with H 2 O 2 ϩ PD-98059 shows that phosphorylation of occludin serine residues was prevented. B: the normalization of phosphoserine data to immunoprecipitated occludin as determined by densitometric analysis revealing a significant 3-fold increase in occludin phosphorylation that was attenuated by PD-98059. Data are shown as the mean Ϯ SD with * P Ͻ 0.05. C26 diated inflammation are accompanied by H 2 O 2 formation and microvascular permeability (14, 15, 33) . Kurose et al. (25) showed that infusion of plateletactivating factor (PAF) to mesenteric microvessels caused increased leukocyte adhesion, H 2 O 2 formation, and microvascular permeability, which were all attenuated by catalase. Similarly, Suematsu et al. (42) demonstrated that PAF administration to mesenteric microvessels resulted in oxidant formation similar to treatment with 800 M tert-butyl hydroperoxide. These observations indicate that H 2 O 2 is intimately involved in PAF-mediated microvascular dysfunction, yet the mechanisms involved are unknown. Because most studies have used nonhuman endothelial cell lines to examine permeability changes due to H 2 O 2 , we evaluated H 2 O 2 -mediated permeability in human endothelial monolayers (22, 30, 35, 36, 37) . In addition, we sought to identify the molecular targets and mechanisms that were involved in H 2 O 2 -mediated increased endothelial solute permeability.
Our data indicate that H 2 O 2 increased HUVEC permeability to a similar magnitude and time course as seen with endothelial cells of other species (22, 30, 35, 37) . In bovine pulmonary artery and aortic endothelial cells, PKC activation contributes to H 2 O 2 -mediated permeability (22, 36) . Studies also have shown that tyrosine kinase activity affects endothelial and epithelial solute properties (4, 41) . However, treatment of HUVEC with the PKC inhibitor chelerythrine chloride or the tyrosine kinase inhibitor tyrphostin 23 failed to prevent H 2 O 2 -mediated permeability. These observations suggested that tyrosine kinase and PKC activity are not involved in H 2 O 2 -mediated increased permeability of human endothelial monolayers and that not all endothelial cell types regulate their solute barrier properties the same way.
Recently, activation of other signal transduction pathways have been identified in H 2 O 2 -treated HUVEC. Huot et al. (19) published data indicating that H 2 O 2 administration causes an increase in ERK1/ ERK2 activity. Additional studies using nonendothelial cell types also have reported that exogenous H 2 O 2 administration causes increased ERK1/ERK2 activity that peaks within 10-15 min (16, 45) . Guyton et al. (16) further demonstrated that H 2 O 2 -mediated increased ERK2 activity was abrogated by expression of a dominant-negative mutant of p21Ras. Lander et al. (26, 27) has also shown that H 2 O 2 increases p21Ras activity by oxidizing the protein. Therefore, we determined the role of ERK1/ERK2 kinase activity in H 2 O 2 -mediated endothelial permeability.
Combined treatment of HUVEC with H 2 O 2 plus the specific MEK1 inhibitor PD-98059 completely prevented H 2 O 2 -mediated permeability. These results support our previous finding that ERK1/ERK2 activity is involved in the regulation of HUVEC solute permeability (24) . Determination of ERK1/ERK2 phosphorylation using an anti-active MAP kinase antibody further suggested that H 2 O 2 significantly increased HUVEC ERK1/ERK2 activation. Moreover, the H 2 O 2 -mediated increase in ERK1/ERK2 phosphorylation was completely prevented by PD-98059. These data suggest that H 2 O 2 -mediated permeability involves MEK1/ERK1/ERK2 signal pathways, or that by blocking MEK1 with PD-98059 activation, other kinases such as ras, rac, rho, or p38 MAP kinase may be involved in the observed cellular events. We feel that this possibility is unlikely because we have previously investigated the effects of PD-98059 alone and found that this agent did not change basal endothelial permeability nor substantially alter endothelial occludin or vascular endothelial cadherin localization (24) . However, we are currently investigating the contribution of p38 MAP kinase in H 2 O 2 -mediated permeability to address these possibilities.
Several groups, including ours, have previously demonstrated that H 2 O 2 -mediated permeability causes gap formation between endothelial cells and the loss of endothelial junctional protein organization (i.e., actin and cadherin) (4, 22, 30, 35, 36) . Because occludin participates in normal endothelial solute barrier, and the direct examination of occludin and ZO-1 has not been reported using this model system, we determined the effect of H 2 O 2 administration on the organization of these tight junctional proteins.
Immunofluorescent staining for these two proteins showed that H 2 O 2 caused a loss of occludin from the endothelial cell junctions and that ZO-1 junctional localization was not altered except for regions where gap formation occurred. Reports have demonstrated that occludin binds directly to the NH 2 -terminal region of ZO-1, which is bound to the actin cytoskeleton (8, 12) . Together, the immunofluorescence and immunoprecipitation data suggested that occludin-ZO-1 binding was reduced by H 2 O 2 administration. Our ZO-1 findings corroborate two previous reports in the literature that show that: 1) ZO-1 remains localized in junctions despite a loss of tight junction protein organization, and 2) ZO-1 junctional localization is no longer observed at regions where endothelial cells are not in contact with one another (29, 31) .
Treatment of cells with either the PKC or tyrosine kinase inhibitor did not prevent this loss of occludin staining at junctions nor did it block gap formation between endothelial cells (data not shown). Interestingly, treatment with the MEK inhibitor PD-98059 ϩ H 2 O 2 actually appeared to enhance occludin junction organization and prevent gap formation, indicating that ERK1/ERK2 pathways are involved in occludin organization at cell-cell junctions. This agrees with our previous finding that VEGF reorganizes occludin junctional localization via the ERK1/ERK2 pathways (24) . These data strongly suggest that occludin disorganization and subsequent gap formation involves ERK1/ ERK2 pathways.
Having observed the dissociation of occludin from the junction, we wanted to determine exactly what was happening to the steady-state levels of tight junctional proteins during H 2 O 2 exposure. As stated, we reported that the amount of occludin protein in the cell regulates the barrier properties of endothelial monolayers (23) . Similarly, we recently have shown that treatment C27 of HUVEC monolayers with organ preservation solutions results in shedding and loss of occludin with increased endothelial permeability (44) . Western analysis showed that H 2 O 2 alone or H 2 O 2 ϩ PD-98059 slightly, yet not significantly, increased occludin steady-state protein levels compared with control monolayers. This observation suggested that the occludin protein was not lost but was reorganized in the endothelial cell.
We next considered how occludin was being reorganized in H 2 O 2 -treated endothelial cells. We have previously reported that H 2 O 2 administration causes bovine pulmonary artery endothelial cells to internalize junctional cadherins (22) . Moreover, earlier reports suggested that tight junction proteins in epithelial cells were endocytosed when exposed to low-extracellular calcium environments (5, 13) . Surface biotinylation followed by occludin immunoprecipitation data showed that occludin was not endocytosed in response to H 2 O 2 . We found that occludin remains on the endothelial cell surface and is dissociated from ZO-1. The combined treatment of H 2 O 2 ϩ PD-98059 showed a significantly greater amount of biotinylated occludin (3-fold) that was accompanied by a significantly greater association with ZO-1. This observation suggests that this combined treatment dramatically enhanced the amount of occludin present on the cell surface. Clearly, the slight and statistically insignificant increase in occludin protein levels are not completely responsible for such a large increase in occludin surface localization, especially because there was no increase in ZO-1 protein levels; however, the contribution of protein synthesis cannot be completely discounted without the use of protein synthesis inhibitors. One possible explanation as to why the combination of H 2 O 2 and PD-98059 causes increased surface localization of occludin is that inhibition of MEK1 activity may affect proteins involved in occludin and tight junction organization, like the recently described tight junctional proteins of the claudin family and junctional adhesion molecule, which might enhance or alter occludin localization (11, 32) . Moreover, occludin could possibly be recruited from intracellular pools. We and others have reported that occludin staining in HUVEC or Madin-Darby canine kidney (MDCK) epithelium occurs in a less continuous, punctate manner with localization at the cell-cell junction and within the cytoplasm, compared with that of human umbilical artery endothelial cells and during extracellular lowcalcium treatments, respectively (23, 34) . However, the precise identification of cytoplasmic structures containing occludin is not well known.
Another possibility that could explain the differences in occludin surface or intracellular localization could be due to different states of occludin phosphorylation. Sakakibara et al. (34) has reported that in MDCK epithelial cells exposed to low-calcium treatments, occludin phosphorylation is decreased and that occludin no longer associates with the cytoskeleton (34) . The authors surmised that in MDCK epithelial cells, phosphorylation of occludin is necessary for binding to the cytoskeleton and functional integration into the tight junction. Another study by Wong (46) demonstrated that occludin phosphorylation was different in the two MDCK strains I and II. The author hypothesized that differences in occludin phosphorylation could possibly explain the differences in transepithelial resistance between the two cell types. In contrast, a study by Cordenonsi et al. (6) reported that in Xenopus development, occludin becomes progressively dephosphorylated after fertilization. This study further demonstrated that the protein kinases casein kinase 2 and p34 cdc2 could, but that MAP kinase and p38 syk tyrosine kinase could not, phosphorylate recombinant chicken occludin in cell-free phosphorylation assays. Unfortunately, the physiologically active kinase responsible for occludin phosphorylation was not identified in this study.
We found that endothelial occludin was only weakly phosphorylated on serine residues basally. Treatment of HUVEC monolayers with H 2 O 2 significantly increased the amount of phosphoserine residues of occludin. Treatment of endothelial cells with H 2 O 2 ϩ PD-98059 showed no such increase in occludin phosphoserine content, strongly suggesting that ERK1/ ERK2 promotes occludin phosphorylation either directly or through an unidentified serine/threonine kinase in the ERK1/ERK2 pathway. In support of our findings, Hirase (17) has recently shown that treatment of HUVEC with histamine causes an increase in solute permeability combined with an increase in occludin phosphoserine content. Pyrilamine, an H 1 antagonist, was reported to prevent phosphorylation of occludin serine residues and blocked histamine-mediated increased permeability. Moreover, Antonetti et al.
(1) has recently reported that VEGF induces phosphorylation of occludin on serine residues in vivo and in vitro. Together with our findings, these observations suggest that HUVEC occludin is not normally phosphorylated on serine residues, and agents that increase solute permeability increase occludin phosphoserine content, which disorganizes occludin localization from the cell junction. Our data demonstrate for the first time that increased occludin phosphorylation is associated with increased endothelial permeability in response to H 2 O 2 .
In conclusion, we report that H 2 O 2 -mediated permeability of HUVEC monolayers involves occludin disorganization on the endothelial surface with loss of ZO-1 association and increased phosphorylation of occludin serine residues mediated by ERK1/ERK2 signal pathways. Future studies are needed to elucidate how the combination of H 2 O 2 and PD-98059 increases the amount of occludin on the cell surface.
